Characterization of gastric cancer stem-like molecular features, immune and pharmacogenomic landscapes

被引:15
作者
Wei, Chen [1 ]
Chen, Mingkai [2 ]
Deng, Wenying [1 ]
Bie, Liangyu [1 ]
Ma, Yijie [1 ]
Zhang, Chi [1 ]
Liu, Kangdong [3 ]
Shen, Wei [4 ]
Wang, Shuyi [5 ,6 ]
Yang, Chaogang [5 ,6 ]
Luo, Suxia [1 ]
Li, Ning [1 ]
机构
[1] Zhengzhou Univ, Henan Canc Hosp, Dept Internal Med, Affiliated Tumor Hosp, Zhengzhou 450001, Peoples R China
[2] Zhengzhou Yihe Hosp, Dept Digest Internal Med, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Acad Med Sci, Coll Med,Dept Pathophysiol, Sch Basic Med Sci,China US Henan Hormel Canc Inst, Zhengzhou, Peoples R China
[4] Xinxiang Med Univ, Dept Internal Med, Affiliated Hosp 1, Xinxiang, Henan, Peoples R China
[5] Wuhan Univ, Dept Gastrointestinal Surg, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China
[6] Wuhan Univ, Dept Gastr & Colorectal Surg Oncol, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
cancer stem cells; gastric cancer; tumor microenvironment; immunotherapy; tumor associated macrophage; prognosis; CELLS; BLOCKADE; EXPRESSION; PROGNOSIS; RESISTANCE; THERAPY; PACKAGE; TARGETS; EMT;
D O I
10.1093/bib/bbab386
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cancer stem cells (CSCs) actively reprogram their tumor microenvironment (TME) to sustain a supportive niche, which may have a dramatic impact on prognosis and immunotherapy. However, our knowledge of the landscape of the gastric cancer stem-like cell (GCSC) microenvironment needs to be further improved. A multi-step process of machine learning approaches was performed to develop and validate the prognostic and predictive potential of the GCSC-related score (GCScore). The high GCScore subgroup was not only associated with stem cell characteristics, but also with a potential immune escape mechanism. Furthermore, we experimentally demonstrated the upregulated infiltration of CD206(+) tumor-associated macrophages (TAMs) in the invasive margin region, which in turn maintained the stem cell properties of tumor cells. Finally, we proposed that the GCScore showed a robust capacity for prediction for immunotherapy, and investigated potential therapeutic targets and compounds for patients with a high GCScore. The results indicate that the proposed GCScore can be a promising predictor of prognosis and responses to immunotherapy, which provides new strategies for the precision treatment of GCSCs.
引用
收藏
页数:17
相关论文
共 70 条
  • [11] Gastric Cancer Stem Cells: Current Insights into the Immune Microenvironment and Therapeutic Targets
    Fu, Lingfeng
    Bu, Luke
    Yasuda, Tadahito
    Koiwa, Mayu
    Akiyama, Takahiko
    Uchihara, Tomoyuki
    Baba, Hideo
    Ishimoto, Takatsugu
    [J]. BIOMEDICINES, 2020, 8 (01)
  • [12] Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
    George, Suzanne
    Miao, Diana
    Demetri, George D.
    Adeegbe, Dennis
    Rodig, Scott J.
    Shukla, Sachet
    Lipschitz, Mikel
    Amin-Mansour, Ali
    Raut, Chandrajit P.
    Carter, Scott L.
    Hammerman, Peter
    Freeman, Gordon J.
    Wu, Catherine J.
    Ott, Patrick A.
    Wong, Kwok-Kin
    Van Allen, Eliezer M.
    [J]. IMMUNITY, 2017, 46 (02) : 197 - 204
  • [13] Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
    Gide, Tuba N.
    Quek, Camelia
    Menzies, Alexander M.
    Tasker, Annie T.
    Shang, Ping
    Holst, Jeff
    Madore, Jason
    Lim, Su Yin
    Velickovic, Rebecca
    Wongchenko, Matthew
    Yan, Yibing
    Lo, Serigne
    Carlino, Matteo S.
    Guminski, Alexander
    Saw, Robyn P. M.
    Pang, Angel
    McGuire, Helen M.
    Palendira, Umaimainthan
    Thompson, John F.
    Rizos, Helen
    da Silva, Ines Pires
    Batten, Marcel
    Scolyer, Richard A.
    Long, Georgina V.
    Wilmott, James S.
    [J]. CANCER CELL, 2019, 35 (02) : 238 - +
  • [14] CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
    Ginestier, Christophe
    Liu, Suling
    Diebel, Mark E.
    Korkaya, Hasan
    Luo, Ming
    Brown, Marty
    Wicinski, Julien
    Cabaud, Olivier
    Charafe-Jauffret, Emmanuelle
    Birnbaum, Daniel
    Guan, Jun-Lin
    Dontu, Gabriela
    Wicha, Max S.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (02) : 485 - 497
  • [15] Dormant tumour cells, their niches and the influence of immunity
    Goddard, Erica T.
    Bozic, Ivana
    Riddell, Stanley R.
    Ghajar, Cyrus M.
    [J]. NATURE CELL BIOLOGY, 2018, 20 (11) : 1240 - 1249
  • [16] Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic
    Groza, Iulia-Monica
    Braicu, Cornelia
    Jurj, Ancuta
    Zanoaga, Oana
    Lajos, Raduly
    Chiroi, Paul
    Cojocneanu, Roxana
    Paun, Diana
    Irimie, Alexandru
    Korban, Schuyler S.
    Achimas-Cadariu, Patriciu
    Berindan-Neagoe, Ioana
    [J]. CANCERS, 2020, 12 (10) : 1 - 21
  • [17] GSVA: gene set variation analysis for microarray and RNA-Seq data
    Haenzelmann, Sonja
    Castelo, Robert
    Guinney, Justin
    [J]. BMC BIOINFORMATICS, 2013, 14
  • [18] Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
    Herbst, Roy S.
    Soria, Jean-Charles
    Kowanetz, Marcin
    Fine, Gregg D.
    Hamid, Omid
    Gordon, Michael S.
    Sosman, Jeffery A.
    McDermott, David F.
    Powderly, John D.
    Gettinger, Scott N.
    Kohrt, Holbrook E. K.
    Horn, Leora
    Lawrence, Donald P.
    Rost, Sandra
    Leabman, Maya
    Xiao, Yuanyuan
    Mokatrin, Ahmad
    Koeppen, Hartmut
    Hegde, Priti S.
    Mellman, Ira
    Chen, Daniel S.
    Hodi, F. Stephen
    [J]. NATURE, 2014, 515 (7528) : 563 - +
  • [19] Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
    Hugo, Willy
    Zaretsky, Jesse M.
    Sun, Lu
    Song, Chunying
    Moreno, Blanca Homet
    Hu-Lieskovan, Siwen
    Berent-Maoz, Beata
    Pang, Jia
    Chmielowski, Bartosz
    Cherry, Grace
    Seja, Elizabeth
    Lomeli, Shirley
    Kong, Xiangju
    Kelley, Mark C.
    Sosman, Jeffrey A.
    Johnson, Douglas B.
    Ribas, Antoni
    Lo, Roger S.
    [J]. CELL, 2016, 165 (01) : 35 - 44
  • [20] Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
    Kim, Seog-Young
    Kang, Jin Wook
    Song, Xinxin
    Kim, Bo Kyoung
    Yoo, Young Dong
    Kwon, Yong Tae
    Lee, Yong J.
    [J]. CELLULAR SIGNALLING, 2013, 25 (04) : 961 - 969